Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Mark Zuckerberg, Priscilla Chan Donate $10M to Advance Health Using Big Data

    Jul 28, 2017, 10:41 AM by Michael Croft
    UC San Francisco | Atul Butte, who is helping to guide UCSF into a new era of computational science and medicine, has been named the Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF.
    Full story
  • Is a shortage of bioinformaticians holding back adoption of precision therapies?

    Jul 28, 2017, 10:36 AM by Michael Croft
    CAMBRIDGE - Jul 28, 2017 - Many key scientists lack essential skills in bioinformatics and this is potentially a bottleneck for therapeutic research in big pharma
    Full story
  • Takeda And Schrödinger Team Up For Drug Discovery

    Jul 27, 2017, 14:02 PM by Michael Croft
    Asian Scientist Magazine | To leverage each other's strengths and accelerate the drug discovery process, Takeda Pharmaceutical Company Limited has teamed up with Schrödinger Incorporated. The multi-target research collaboration is directed at treating diseases that are aligned with Takeda's core therapeutic areas of interest.
    Full story
  • Adaptive Biotechnologies Announces Translational Collaboration with National Cancer Institute

    Jul 27, 2017, 13:34 PM by Michael Croft
    SEATTLE, WA, UNITED STATES - Jul 26, 2017 - Adaptive Biotechnologies, a pioneer in combining next-generation sequencing and expert bioinformatics to profile T-cell and B-cell receptors (TCRs and BCRs) of the adaptive immune system, today announced a translational collaboration with the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI), part of the National Institutes of Health
    Full story
  • Pharma Companies Reshape Focus In R&D

    Jul 27, 2017, 11:55 AM by Michael Croft

    Bio-IT World Brief | Rare diseases have found themselves on the chopping block after a spate of pharma reorganizations.

    Full story
  • First Human Embryos Edited in U.S.

    Jul 27, 2017, 09:40 AM by Michael Croft
    MIT Technology Review | Researchers have demonstrated they can efficiently improve the DNA of human embryos.
    Full story
  • Merck’s Cyberattack And Biopharma’s Rising Interest In Cybersecurity

    Jul 26, 2017, 09:40 AM by Michael Croft

    Bio-IT World | Cybersecurity has hardly been biopharma’s main focus, but it demands attention given the volume of collaborations, the varying levels of security each partner maintains, the widespread use of personal devices to access a sponsor’s system, and the importance of protecting a company’s most precious intellectual property—its data.

    Full story
  • BioreclamationIVT Appoints Vice President of Global Quality and Compliance

    Jul 26, 2017, 08:14 AM by Michael Croft
    WESTBURY, NY - Jul 26, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has appointed Karen Sasse to the newly-created position of vice president of global quality and compliance
    Full story
  • Optibrium and Bugworks Sign Agreement for StarDrop License

    Jul 25, 2017, 12:01 PM by Michael Croft
    CAMBRIDGE, UK - Jul 25, 2017 - CAMBRIDGE, UK and BENGALURU, INDIA, 25 July 2017 – Optibrium™, a developer of software for small molecule discovery, and Bugworks Research Inc
    Full story
  • Dont run biomedical science as a business

    Jul 25, 2017, 11:01 AM by Michael Croft
    Nature News & Comment | Science should abandon its assembly-line mentality and rebuild for quality, not quantity, argues Michele Pagano.
    Full story
  • Catch of the day: A net full of trees

    Jul 25, 2017, 06:18 AM by Michael Croft
    NORWICH, ENGLAND - Jul 25, 2017 - Catch of the day: A net full of trees SPECTRE, a new open-source software package, simplifies the complex business of creating phylogenetic networks and trees
    Full story
  • New research highlights lack of confidence in serialization preparations

    Jul 25, 2017, 04:45 AM by Michael Croft
    - Jul 25, 2017 - More than one third (40 per cent) of pharmaceutical industry professionals are not confident that they will meet serialization deadlines in the US and Europe, according to new industry research
    Full story
  • Definiens Forearms Organization for Strategic Expansion

    Jul 24, 2017, 16:50 PM by Michael Croft
    MUNICH, GERMANY - Jul 24, 2017 -  Definiens, the leader in Tissue Phenomics® and provider of solutions from biomarker discovery to meaningful diagnostics, today announced the strengthening of its leadership team
    Full story
  • IndieBio-Backed Startups Gain Exclusive Access to Customized Science Exchange Outsourced R&D Platform, Helping to Level Playing Field with Larger Biopharma Companies

    Jul 24, 2017, 12:38 PM by Michael Croft
    PALO ALTO, CA, UNITED STATES - Jul 10, 2017 - Science Exchange, the world’s leading platform for outsourced research and development (R&D), today announced a strategic partnership with IndieBio, the world’s largest seed biotech accelerator
    Full story
  • Science Exchange First & Only R&D Outsourcing Platform to Receive EU-U.S. Privacy Shield Framework Certification

    Jul 24, 2017, 12:34 PM by Michael Croft
    PALO ALTO, MA, UNITED STATES - Jul 20, 2017 - Science Exchange today announced that it is the first and only R&D outsourcing platform to receive EU-U
    Full story
  • Helix Launches First Online Consumer Marketplace For DNA-Powered Products

    Jul 24, 2017, 08:45 AM by Michael Croft

    Bio-IT World Brief | Helix today launched the first online marketplace for DNA-powered products that offer insights on ancestry, entertainment, family, fitness, health, and nutrition. Helix’s inaugural marketplace partners include Admera Health, Azumio, DNAFit, Dot One, EverlyWell, Exploragen, Genome Medical, Insitome, Lose It!, National Geographic, Sema4, Titanovo, and Vinome.

    Full story
  • FDAnews Joins WIRB-Copernicus Group

    Jul 21, 2017, 14:19 PM by Michael Croft
    PRINCETON, NJ - Jul 20, 2017 - WIRB-Copernicus Group (WCG), the world’s leading provider of solutions to measurably improve the quality and efficiency of clinical research, announced today that it has acquired FDAnews, which provides global regulatory information for executives in the clinical research, biopharmaceutical and medical device industries
    Full story
  • US Defence Agencies Grapple With Gene Drives

    Jul 21, 2017, 12:45 PM by Michael Croft
    Nature News & Comment | National security community examines the risks and benefits of technology to quickly spread genetic modifications.
    Full story
  • Active Dashboard 2 allows easy access to process performance data

    Jul 20, 2017, 14:54 PM by Michael Croft
    GOETTINGEN, GERMANY - Jul 20, 2017 - Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, has launched the Active Dashboard 2, an advanced software solution
    Full story
  • Supercomputer Maker Cray Cutting 14% Of workforce, 190 Jobs, Seeking To Save $25M Per Year

    Jul 20, 2017, 13:44 PM by Michael Croft
    GeekWire | Seattle supercomputer maker Cray plans to cut 190 jobs, representing about 14% of its global workforce, as part of a restructuring plan meant to cut costs.
    Full story
  • «
  • 311
  • 312
  • 313
  • 314
  • 315
  • 316 (current)
  • 317
  • 318
  • 319
  • 320
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy